163.48
price up icon1.39%   2.08
 
loading

Warum fällt Davita Inc-Aktie (DVA)?

Wir haben während der Handelssitzung 2024-10-30 einen Rückgang der Aktie Davita Inc (DVA) um 10.80% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!
2023-10-11:

Shares of Davita (DVA) dropped by 16.86% from $91.28 to $75.89 in the trading on Wednesday, October 11, 2023. The reason why DVA stock down is due to a competitor's successful kidney disease prevention drug. However, the stock drop was not exclusive to Davita, as some other dialysis companies like Fresenius and Baxter International also suffered losses. This market turbulence was triggered by Novo Nordisk's early termination of a phase 3 trial for Ozempic (semaglutide), which showed remarkable effectiveness in slowing kidney disease progression in type 2 diabetes and chronic kidney disease patients, potentially disrupting the need for dialysis. This setback compounded Davita' existing struggles, now that the announcement by Novo Nordisk hurts kidney dialysis provider.

medical_care_facilities UHS
$197.00
price down icon 0.56%
medical_care_facilities FMS
$21.84
price up icon 0.00%
medical_care_facilities THC
$147.17
price down icon 3.78%
medical_care_facilities EHC
$98.87
price down icon 0.05%
medical_care_facilities CHE
$552.00
price up icon 0.41%
Kapitalisierung:     |  Volumen (24h):